APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

AI-Based Medical Transcription

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI-Based Medical Transcription Market Outlook and Growth Opportunities 2026

Report ID 174055900415 April 2026Not stated

Choose your research edition.

Industry ResearchAI-Based Medical Transcription Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-Based Medical Transcription Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI-Based Medical Transcription Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-Based Medical Transcription Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal AI-Based Medical Transcription Market Analysis and Forecast 2026-2032237 pages · $4,950 USD

Market perspective

The global AI-Based Medical Transcription market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI-Based Medical Transcription is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI-Based Medical Transcription is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-Based Medical Transcription is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI-Based Medical Transcription market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI-Based Medical Transcription market include Nuance Communications, Abridge, DeepScribe, Heidi Health, InfraWare, Rev, Suki AI, Otter.ai and Verbit.ai, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI-Based Medical Transcription market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI-Based Medical Transcription and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI-Based Medical Transcription revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI-Based Medical Transcription market.

AI-Based Medical Transcription Segment by Company

Nuance Communications

Abridge

DeepScribe

Heidi Health

InfraWare

Rev

Suki AI

Otter.ai

Verbit.ai

Freed

AI-Based Medical Transcription Segment by Type

Software

Services

AI-Based Medical Transcription Segment by Application

Hospitals

Clinics

Diagnostic Centers

Others

AI-Based Medical Transcription Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI-Based Medical Transcription status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI-Based Medical Transcription key companies, revenue, market share, and recent developments.

3. To split the AI-Based Medical Transcription breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI-Based Medical Transcription market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI-Based Medical Transcription significant trends, drivers, influence factors in global and regions.

6. To analyze AI-Based Medical Transcription competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-Based Medical Transcription market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-Based Medical Transcription and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-Based Medical Transcription.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-Based Medical Transcription industry.

Chapter 3: Detailed analysis of AI-Based Medical Transcription company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI-Based Medical Transcription in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI-Based Medical Transcription in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI-Based Medical Transcription Industry Trends Table 2. AI-Based Medical Transcription Industry Drivers Table 3. AI-Based Medical Transcription Industry Opportunities and Challenges Table 4. AI-Based Medical Transcription Industry Restraints Table 5. Global AI-Based Medical Transcription Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI-Based Medical Transcription Revenue Share by Company (2021-2026) Table 7. Global AI-Based Medical Transcription Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI-Based Medical Transcription Key Company Manufacturing Base & Headquarters Table 9. Global AI-Based Medical Transcription Company, Product Type & Application Table 10. Global AI-Based Medical Transcription Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI-Based Medical Transcription by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Software Table 15. Significant Companies of Services Table 16. Global AI-Based Medical Transcription Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI-Based Medical Transcription Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI-Based Medical Transcription Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI-Based Medical Transcription Sales Value Share by Type (2021-2026) Table 20. Global AI-Based Medical Transcription Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Clinics Table 23. Significant Companies of Diagnostic Centers Table 24. Significant Companies of Others Table 25. Global AI-Based Medical Transcription Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI-Based Medical Transcription Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global AI-Based Medical Transcription Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global AI-Based Medical Transcription Sales Value Share by Application (2021-2026) Table 29. Global AI-Based Medical Transcription Sales Value Share by Application (2027-2032) Table 30. Global AI-Based Medical Transcription Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI-Based Medical Transcription Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global AI-Based Medical Transcription Sales Value Share by Region (2021-2026) Table 33. Global AI-Based Medical Transcription Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global AI-Based Medical Transcription Sales Value Share by Region (2027-2032) Table 35. Global AI-Based Medical Transcription Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI-Based Medical Transcription Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global AI-Based Medical Transcription Sales Value Market Share by Country (2021-2026) Table 38. Global AI-Based Medical Transcription Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global AI-Based Medical Transcription Sales Value Market Share by Country (2027-2032) Table 40. Nuance Communications Company Information Table 41. Nuance Communications Business Overview Table 42. Nuance Communications AI-Based Medical Transcription Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Nuance Communications AI-Based Medical Transcription Product Portfolio Table 44. Nuance Communications Recent Development Table 45. Abridge Company Information Table 46. Abridge Business Overview Table 47. Abridge AI-Based Medical Transcription Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Abridge AI-Based Medical Transcription Product Portfolio Table 49. Abridge Recent Development Table 50. DeepScribe Company Information Table 51. DeepScribe Business Overview Table 52. DeepScribe AI-Based Medical Transcription Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. DeepScribe AI-Based Medical Transcription Product Portfolio Table 54. DeepScribe Recent Development Table 55. Heidi Health Company Information Table 56. Heidi Health Business Overview Table 57. Heidi Health AI-Based Medical Transcription Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Heidi Health AI-Based Medical Transcription Product Portfolio Table 59. Heidi Health Recent Development Table 60. InfraWare Company Information Table 61. InfraWare Business Overview Table 62. InfraWare AI-Based Medical Transcription Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. InfraWare AI-Based Medical Transcription Product Portfolio Table 64. InfraWare Recent Development Table 65. Rev Company Information Table 66. Rev Business Overview Table 67. Rev AI-Based Medical Transcription Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Rev AI-Based Medical Transcription Product Portfolio Table 69. Rev Recent Development Table 70. Suki AI Company Information Table 71. Suki AI Business Overview Table 72. Suki AI AI-Based Medical Transcription Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Suki AI AI-Based Medical Transcription Product Portfolio Table 74. Suki AI Recent Development Table 75. Otter.ai Company Information Table 76. Otter.ai Business Overview Table 77. Otter.ai AI-Based Medical Transcription Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Otter.ai AI-Based Medical Transcription Product Portfolio Table 79. Otter.ai Recent Development Table 80. Verbit.ai Company Information Table 81. Verbit.ai Business Overview Table 82. Verbit.ai AI-Based Medical Transcription Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Verbit.ai AI-Based Medical Transcription Product Portfolio Table 84. Verbit.ai Recent Development Table 85. Freed Company Information Table 86. Freed Business Overview Table 87. Freed AI-Based Medical Transcription Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Freed AI-Based Medical Transcription Product Portfolio Table 89. Freed Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. AI-Based Medical Transcription Product Image Figure 2. Global AI-Based Medical Transcription Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-Based Medical Transcription Market Size (2021-2032) & (US$ Million) Figure 4. Global AI-Based Medical Transcription Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Software Image Figure 8. Services Image Figure 9. Global AI-Based Medical Transcription Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI-Based Medical Transcription Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI-Based Medical Transcription Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Clinics Image Figure 14. Diagnostic Centers Image Figure 15. Others Image Figure 16. Global AI-Based Medical Transcription Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI-Based Medical Transcription Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global AI-Based Medical Transcription Sales Value Share by Application (2021-2032) Figure 19. Global AI-Based Medical Transcription Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global AI-Based Medical Transcription Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America AI-Based Medical Transcription Sales Value (2021-2032) & (US$ Million) Figure 22. North America AI-Based Medical Transcription Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe AI-Based Medical Transcription Sales Value (2021-2032) & (US$ Million) Figure 24. Europe AI-Based Medical Transcription Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific AI-Based Medical Transcription Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific AI-Based Medical Transcription Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America AI-Based Medical Transcription Sales Value (2021-2032) & (US$ Million) Figure 28. South America AI-Based Medical Transcription Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa AI-Based Medical Transcription Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa AI-Based Medical Transcription Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt AI-Based Medical Transcription Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Software
  • Services
Applications
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others
Companies covered
  • Nuance Communications
  • Abridge
  • DeepScribe
  • Heidi Health
  • InfraWare
  • Rev
  • Suki AI
  • Otter.ai
  • Verbit.ai
  • Freed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI-Based Medical Transcription Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI-Based Medical Transcription Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI-Based Medical Transcription Market Dynamics
  1. 2.1 AI-Based Medical Transcription Industry Trends
  2. 2.2 AI-Based Medical Transcription Industry Drivers
  3. 2.3 AI-Based Medical Transcription Industry Opportunities and Challenges
  4. 2.4 AI-Based Medical Transcription Industry Restraints
3 AI-Based Medical Transcription Market by Company
  1. 3.1 Global AI-Based Medical Transcription Company Revenue Ranking in 2025
  2. 3.2 Global AI-Based Medical Transcription Revenue by Company (2021-2026)
  3. 3.3 Global AI-Based Medical Transcription Company Ranking (2024-2026)
  4. 3.4 Global AI-Based Medical Transcription Company Manufacturing Base and Headquarters
  5. 3.5 Global AI-Based Medical Transcription Company Product Type and Application
  6. 3.6 Global AI-Based Medical Transcription Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI-Based Medical Transcription Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI-Based Medical Transcription Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI-Based Medical Transcription Market by Type
  1. 4.1 AI-Based Medical Transcription Type Introduction
  2. 4.1.1 Software
  3. 4.1.2 Services
  4. 4.2 Global AI-Based Medical Transcription Sales Value by Type
  5. 4.2.1 Global AI-Based Medical Transcription Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI-Based Medical Transcription Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI-Based Medical Transcription Sales Value Share by Type (2021-2032)
5 AI-Based Medical Transcription Market by Application
  1. 5.1 AI-Based Medical Transcription Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Diagnostic Centers
  5. 5.1.4 Others
  6. 5.2 Global AI-Based Medical Transcription Sales Value by Application
  7. 5.2.1 Global AI-Based Medical Transcription Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI-Based Medical Transcription Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI-Based Medical Transcription Sales Value Share by Application (2021-2032)
6 AI-Based Medical Transcription Regional Value Analysis
  1. 6.1 Global AI-Based Medical Transcription Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI-Based Medical Transcription Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI-Based Medical Transcription Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI-Based Medical Transcription Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI-Based Medical Transcription Sales Value (2021-2032)
  7. 6.3.2 North America AI-Based Medical Transcription Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI-Based Medical Transcription Sales Value (2021-2032)
  10. 6.4.2 Europe AI-Based Medical Transcription Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI-Based Medical Transcription Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI-Based Medical Transcription Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI-Based Medical Transcription Sales Value (2021-2032)
  16. 6.6.2 South America AI-Based Medical Transcription Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI-Based Medical Transcription Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI-Based Medical Transcription Sales Value Share by Country, 2025 VS 2032
7 AI-Based Medical Transcription Country-level Value Analysis
  1. 7.1 Global AI-Based Medical Transcription Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI-Based Medical Transcription Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI-Based Medical Transcription Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI-Based Medical Transcription Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI-Based Medical Transcription Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI-Based Medical Transcription Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI-Based Medical Transcription Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Nuance Communications
  2. 8.1.1 Nuance Communications Company Information
  3. 8.1.2 Nuance Communications Business Overview
  4. 8.1.3 Nuance Communications AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Nuance Communications AI-Based Medical Transcription Product Portfolio
  6. 8.1.5 Nuance Communications Recent Developments
  7. 8.2 Abridge
  8. 8.2.1 Abridge Company Information
  9. 8.2.2 Abridge Business Overview
  10. 8.2.3 Abridge AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Abridge AI-Based Medical Transcription Product Portfolio
  12. 8.2.5 Abridge Recent Developments
  13. 8.3 DeepScribe
  14. 8.3.1 DeepScribe Company Information
  15. 8.3.2 DeepScribe Business Overview
  16. 8.3.3 DeepScribe AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DeepScribe AI-Based Medical Transcription Product Portfolio
  18. 8.3.5 DeepScribe Recent Developments
  19. 8.4 Heidi Health
  20. 8.4.1 Heidi Health Company Information
  21. 8.4.2 Heidi Health Business Overview
  22. 8.4.3 Heidi Health AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Heidi Health AI-Based Medical Transcription Product Portfolio
  24. 8.4.5 Heidi Health Recent Developments
  25. 8.5 InfraWare
  26. 8.5.1 InfraWare Company Information
  27. 8.5.2 InfraWare Business Overview
  28. 8.5.3 InfraWare AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  29. 8.5.4 InfraWare AI-Based Medical Transcription Product Portfolio
  30. 8.5.5 InfraWare Recent Developments
  31. 8.6 Rev
  32. 8.6.1 Rev Company Information
  33. 8.6.2 Rev Business Overview
  34. 8.6.3 Rev AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Rev AI-Based Medical Transcription Product Portfolio
  36. 8.6.5 Rev Recent Developments
  37. 8.7 Suki AI
  38. 8.7.1 Suki AI Company Information
  39. 8.7.2 Suki AI Business Overview
  40. 8.7.3 Suki AI AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Suki AI AI-Based Medical Transcription Product Portfolio
  42. 8.7.5 Suki AI Recent Developments
  43. 8.8 Otter.ai
  44. 8.8.1 Otter.ai Company Information
  45. 8.8.2 Otter.ai Business Overview
  46. 8.8.3 Otter.ai AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Otter.ai AI-Based Medical Transcription Product Portfolio
  48. 8.8.5 Otter.ai Recent Developments
  49. 8.9 Verbit.ai
  50. 8.9.1 Verbit.ai Company Information
  51. 8.9.2 Verbit.ai Business Overview
  52. 8.9.3 Verbit.ai AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Verbit.ai AI-Based Medical Transcription Product Portfolio
  54. 8.9.5 Verbit.ai Recent Developments
  55. 8.10 Freed
  56. 8.10.1 Freed Company Information
  57. 8.10.2 Freed Business Overview
  58. 8.10.3 Freed AI-Based Medical Transcription Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Freed AI-Based Medical Transcription Product Portfolio
  60. 8.10.5 Freed Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst